Literature DB >> 12163967

Gallstone cholangitis: a 10-year experience of combined endoscopic and laparoscopic treatment.

L Sarli1, D Iusco, G Sgobba, L Roncoroni.   

Abstract

BACKGROUND: To date, no procedure has yet been identified as the gold standard for the treatment of gallstone cholangitis in the laparoscopic era.
METHODS: The data of 109 consecutive patients with acute cholangitis were prospectively entered into a computerized database. All patients were managed according to a standard protocol. The main treatments were endoscopic retrograde cholangiography (ERC) combined with endoscopic sphincterotomy (ES), followed by interval laparoscopic cholecystectomy (LC). Patients in whom ERC or endoscopic stone clearance failed were managed by emergency open common bile duct exploration. LC was performed with a standardized four-cannula technique. The mean duration of surgery, conversion rate, and postoperative outcome of these patients were evaluated.
RESULTS: ERC was successful in 103 patients (94.5%). In five of these patients (4.8%), no bile duct stones were found. The 98 patients (95.2%) with common bile duct stones were referred for ES. The bile duct stones were successfully removed after ES in 93 cases (94.9%). The overall failure rate of ERC and ES for choledocholithiasis was 10.1%. Self-limiting pancreatitis occurred in four patients (4.3%). Overall, two of the 109 patients died (1.8%). After ES, 81 patients underwent LC. LC was performed successfully in 74 patients (91.3%). Conversion to open surgery was required in seven patients (8.7%). The morbidity rate after cholecystectomy was 7.4%; the morbidity rate after open bile duct exploration was 36.4% (p<0.05). Fifteen patients were managed conservatively after initial endoscopic management of their cholangitis. The overall incidence of recurrent biliary symptoms was significantly higher among patients with gallbladder in place than for patients who underwent cholecystectomy (38.5% vs 1.5%, p<0.001).
CONCLUSIONS: ES followed by LC is a safe and effective approach for the management of gallstone cholangitis; cholecystectomy should be performed in patients with gallstone cholangitis unless the operative risk is extremely high. These high operative risk patients and those who refuse surgery after ES should be warned that they are at high risk for recurrent biliary symptoms.

Entities:  

Mesh:

Year:  2002        PMID: 12163967     DOI: 10.1007/s00464-001-9133-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  32 in total

1.  Laparoscopic cholecystectomy and intraoperative endoscopic sphincterotomy in the treatment of cholecysto-choledocholithiasis.

Authors:  N Basso; G Pizzuto; D Surgo; A Materia; G Silecchia; A Fantini; F Fiocca; P Trentino
Journal:  Gastrointest Endosc       Date:  1999-10       Impact factor: 9.427

2.  Endoscopic biliary drainage for severe acute cholangitis.

Authors:  E C Lai; F P Mok; E S Tan; C M Lo; S T Fan; K T You; J Wong
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

3.  Identification of bile duct stones in patients undergoing laparoscopic cholecystectomy.

Authors:  W P Joyce; R Keane; G J Burke; M Daly; J Drumm; T J Egan; P V Delaney
Journal:  Br J Surg       Date:  1991-10       Impact factor: 6.939

4.  Coelioscopic cholecystectomy. Preliminary report of 36 cases.

Authors:  F Dubois; P Icard; G Berthelot; H Levard
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

5.  Operative cholangiography: a study of observer variation.

Authors:  I M Macintyre; I A Goulbourne; J M Gollock; D C Grieve
Journal:  J R Coll Surg Edinb       Date:  1988-04

6.  E.A.E.S. multicenter prospective randomized trial comparing two-stage vs single-stage management of patients with gallstone disease and ductal calculi.

Authors:  A Cuschieri; E Lezoche; M Morino; E Croce; A Lacy; J Toouli; A Faggioni; V M Ribeiro; J Jakimowicz; J Visa; G B Hanna
Journal:  Surg Endosc       Date:  1999-10       Impact factor: 4.584

7.  Biliary endoprosthesis as an alternative to endoscopic nasobiliary drainage in patients with acute cholangitis.

Authors:  S P Misra; M Dwivedi
Journal:  Endoscopy       Date:  1996-11       Impact factor: 10.093

8.  Laparoscopic cholecystectomy combined with endoscopic sphincterotomy and stone extraction or laparoscopic choledochoscopy and electrohydraulic lithotripsy for management of cholelithiasis with choledocholithiasis.

Authors:  M E Arregui; C J Davis; A M Arkush; R F Nagan
Journal:  Surg Endosc       Date:  1992 Jan-Feb       Impact factor: 4.584

9.  Endoscopic sphincterotomy and biliary drainage in patients with cholangitis due to common bile duct stones.

Authors:  J Boender; G A Nix; M A de Ridder; J Dees; H E Schütte; H R van Buuren; M van Blankenstein
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

10.  Common bile duct exploration in the era of laparoscopic surgery.

Authors:  M E Stoker
Journal:  Arch Surg       Date:  1995-03
View more
  4 in total

1.  Original single-incision laparoscopic cholecystectomy for acute inflammation of the gallbladder.

Authors:  Kazunari Sasaki; Goro Watanabe; Masamichi Matsuda; Masaji Hashimoto
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Timing of cholecystectomy after endoscopic sphincterotomy for common bile duct stones.

Authors:  Anandi H W Schiphorst; Marc G H Besselink; Djamila Boerma; Robin Timmer; Marinus J Wiezer; Karel J van Erpecum; Ivo A M J Broeders; Bert van Ramshorst
Journal:  Surg Endosc       Date:  2008-02-13       Impact factor: 4.584

3.  Resistant pathogens in biliary obstruction: importance of cultures to guide antibiotic therapy.

Authors:  Michael J Englesbe; Lillian G Dawes
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

4.  Factors influencing the successful completion of laparoscopic cholecystectomy.

Authors:  Ashfaq Chandio; Suzanne Timmons; Aamir Majeed; Aongus Twomey; Fuad Aftab
Journal:  JSLS       Date:  2009 Oct-Dec       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.